Monitoring of biomolecules in the human body can help track wellness levels, diagnose diseases, and evaluate therapeutic outcomes. In particular, the amount and location of hemoglobin in the body provide critical information for perfusion or blood accumulation in that area. Low blood perfusion inside the body may result in severe organ dysfunctions. It can happen in many kinds of diseases (such as myocardial infarction, post-cardiac arrest syndrome, and vascular diseases of the extremities), or after surgery (such as organ transplant). On the contrary, accumulation of blood is often a sign of inflammation, trauma, or cancer. For example, cysts with many possible types of biofluids inside may be found throughout the human body. Bloody cysts are suspicious and should be further examined and closely monitored for the risk of malignant tumors. Continuous monitoring can benefit understanding and diagnosing these pathophysiological conditions, and thus enable timely medical intervention to achieve better outcome. However, existing methods are not designed for continuous functioning on individual patients: some necessitate costly equipment, such as magnetic resonance imaging: some rely on radioactive tracers, such as positron emission tomography. Ultrasonography can image internal tissues and blood flow, but requires an operator and a separate lasing system for biomolecule sensing. The recent advances in soft electronics have given rise to soft patches that can adhere to the human skin for continuous health monitoring. These devices have demonstrated their capability in biomolecule sensing based on electrochemical reactions and optics. However, existing soft patches can only sense biomolecules close to the skin surface. None of them has access to biomolecules in deep tissues, which have a stronger and faster correlation with the physiological and metabolic processes in the human body than those close to the skin surface.
Conventionally, there are several non-invasive methods for detecting biomolecules with high penetration depth (>10 cm) such as magnetic resonance imaging (MRI) and positron emission tomography (PET). MRI leverages the different magnetic properties of various biomolecules to generate images. More specifically, those biomolecules possess multiple relaxation times after receiving radiofrequency pulses. PET is based on the detection of two annihilation photons, which are generated by collisions of the injected radioactive tracers and electrons within the tissue. The tracers will only couple with the target molecules so that high contrast will be achieved. However, the existence of radioactive tracers prevents this technique from long-term use. For these two methods, the associated equipment is too cumbersome and expensive, thus impossible for wearable long-term health monitoring.
Several optical methods are used for biomolecular imaging. The principle of fluorescence imaging is that materials will emit fluorescent light at a specific wavelength after absorbing high energy photons. Different molecules possessing various molecular energy structures result in various fluorescence. Although the spatial resolution is high (˜4 μm), this technique is highly limited by its shallow penetration depth (˜3 mm). Optical coherence tomography (OCT) typically uses near-infrared light for imaging. The backscattered light is measured with an interferometric setup to reconstruct the depth profile of the tissue. But the penetration depth is still limited (˜2 mm)7.
Photoacoustic imaging involves shining a laser beam onto tissues. After that, the light energy is absorbed by the biomolecules and converted to mechanical vibration energy, i.e., photoacoustic waves. Photoacoustic imaging entails several advantages compared to the aforementioned optical imaging: (1) by illuminating various molecules at different wavelengths, photoacoustic tomography exhibits high contrasts regarding chemical compositions: (2) the spatial information of biomolecules is encoded in the ultrasound waves, which has relatively weak attenuation in biological tissues. Therefore, photoacoustic imaging can achieve high spatial resolution (tens of micrometers) mapping of biomolecules in deep tissues (several centimeters in depth). As of now, existing photoacoustic imaging devices are bulky and cumbersome, not suitable for wearable long-term continuous use.
In one aspect, a flexible and stretchable photoacoustic patch is provided that inherits the merits of photoacoustic imaging, which is biomolecular selectivity and high imaging resolution in deep tissues. Also, the flexible and stretchable configuration allows the device to be conformally attached to the skin, which can potentially enable convenient and continuous measurements on the go. In certain embodiments, the photoacoustic patch, achieved a detection depth >2 cm with a lateral resolution of 0.59 mm and an axial resolution of 0.86 mm in tissues.
Skin-like wearable patches that integrate various kinds of sensors can monitor the health and wellness of the human body. Existing skin-like wearable patches can sense biomolecules in sweat, saliva, and tears on the skin surface, or interstitial fluids with micro needles. But conventional existing patches do not have access to those biomolecules embedded deeply underneath the skin (>1 cm). Importantly, those biomolecules in deep tissues should have a stronger and faster correlation to the dynamic processes inside the human body. The wearable photoacoustic patch described herein can be used to add a new sensing dimension for chemical signals in the human body using soft electronics. Furthermore, the wearable patch can map and monitor core temperature in deep tissues with high accuracy and quick response. When core temperature can be detected by an invasive catheter or by heat-flux-model-based wearable temperature sensors. However, these methods have slow response speed (about several hundreds of seconds) and lack capability of temperature mapping. The wearable patch described herein can map and monitor the core temperature in deep tissues with high accuracy and quick response.
Conventional photoacoustic imaging systems use a laser source to generate ultrasound waves in tissues and ultrasound transducers to receive photoacoustic waves. Laser equipment is generally very bulky and heavy, not suitable for wearing. Safety regulations also require the operation of lasers by professionals. Even though some reported studies introduced the applications of laser diodes or LEDs as laser sources, nobody reported using vertical cavity surface emitting laser (VCSEL) bare dies, which have extremely small thickness, ˜200 micrometers, and are thus challenging to be integrated on the soft electronic platform. Furthermore, all the reported photoacoustic studies utilize bulky ultrasound transducers to receive photoacoustic waves.
This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter. Furthermore, the claimed subject matter is not limited to implementations that solve any or all disadvantages noted in any part of this disclosure.
Described herein, in one aspect, is a wearable photoacoustic patch for continuous sensing of biomolecules in deep tissues. The patch is stretchable and/or flexible so that it conforms to the surface on which it is attached, such as a subject's skin or other tissue. The device integrates an array of high-power laser diodes (e.g., VCSELs) and piezoelectric transducers, which are interconnected by serpentine metal electrodes and encapsulated in an elastomeric matrix. Pulsed laser emitted from the VCSEL array excites hemoglobin molecules to radiate acoustic waves. Those photoacoustic waves will be received by the transducer array and then processed to reconstruct a 3D map of the hemoglobin with a sub-millimeter resolution. Moreover, the photoacoustic signal amplitude has a linear relationship with the media temperature, which provides a noninvasive way for core temperature measurement with a high spatial resolution and fast response. That is, the device integrates laser sources and ultrasonic transducers into an electronic patch.
The laser beams are diffused in deep tissues. Hemoglobin molecules will undergo thermoelastic expansion after absorbing optical energy and collapse when the energy is absent. Therefore, when illuminated by the pulsed laser from the VCSEL array, hemoglobin will vibrate and emit photoacoustic waves. The piezoelectric transducers will receive the photoacoustic waves and generate the spatial distribution of the wave emitters. Therefore, photoacoustic imaging takes advantages of the unique absorption characteristics of biomolecules and highly penetrating acoustic waves to achieve high spatial resolution mapping of biomolecules in deep tissues.
In this particular embodiment the patch includes 24 VCSELs that are evenly distributed in four equally spaced columns. An illustrative layout and method of fabricating the patch will be discussed below in connection with
The VCSELs that are used may be high power VCSELS to achieve a high detection depth and a large signal-to-noise ratio (SNR). A wavelength of 850 nm may be used because it has deep tissue penetration and is in the first optical window for probing human tissues. Hemoglobin also has the dominant optical absorption coefficient compared with other molecules, such as water and lipid. Furthermore, VCSEL at 850 nm wavelength is the most widely available, because on one hand, 850 nm is a common fiber optical wavelength whose attenuation in fibers is relatively low; and on the other hand, silicon-based 850 nm photodetectors are low-cost and widely used.
The receiving transducer element may be composed of a piezoelectric layer and a backing layer (see
The as-fabricated soft photoacoustic patch is mechanically and electrically robust.
The optical energy distribution in the tissue should be as uniform as possible to minimize systematic artifacts introduced to the photoacoustic images. Optical attenuation needs to be minimal to ensure maximum detection depth.
VCSELs in operation will generate a lot of heat. Excessive heat will not only raise safety concerns, but also degrade the VCSEL performance31 and change the sensitivity of ultrasound transducers (see
For quantitative photoacoustic studies, it is critical for the transducer array to have a uniform distribution of detection sensitivity to photoacoustic signals in the target region.
The impulse response is a critical characteristic of a sensing system (see
Imaging resolutions are characterized based on a linear source. Photoacoustic images are reconstructed based on signals generated by hairs embedded in gelatin phantoms at different depths, which are well-established for resolution characterization36-39.
The wavelength of 850 nm is critical for a high penetration depth in human tissues. Additionally, for photoacoustic mapping of hemoglobin amongst other biomolecules in the tissue, a laser wavelength where hemoglobin absorption is dominant needs to be selected. To characterize the sensing selectivity at this wavelength, we tested cyst phantoms with five different biofluid inclusions, including water, plasma, milk, fat, and bovine whole blood, in transparent colorless silicone tubes embedded underneath a 2 cm thick porcine tissue (see
The particular embodiment of the patch described herein has 16 rows of transducers that form 13 linear arrays, each of which can produce a 2D photoacoustic image. Combining the 13 images, the patch can generate a 3D map of hemoglobin. The 3D mapping performance is tested on two crossed silicone tubes filled with bovine blood embedded underneath a 2 cm thick porcine tissue.
Core temperature is critical for governing the essential functions of the body and should be maintained near 37° C. It typically fluctuates within 1° C. according to circadian rhythm, but can reach ˜40° C. amid strenuous workload or ˜35.6° C. in extremely cold environments. A significant deviation of the core temperature indicates failing thermoregulation with dire consequences, sometimes life-threatening47. Most of the soft patches can only measure the temperature on the skin surface, which can easily be affected by the external environment and thus has a weak correlation to the core temperature. Noninvasive sensing of core temperature is mainly based on Zero-Heat-Flux or Dual-Heat-Flux thermal models, which have long response times (˜3 min) and limited detection depths (˜1 cm.). Photoacoustic signals are generated when the biomolecules convert the pulsed optical energy to mechanical energy in the form of photoacoustic waves. In the range of 10˜55° C., there is a linear relationship between the amplitude of photoacoustic waves and the temperature53, allowing the measurement of temperature by the photoacoustic approach. To test its ability to measure core temperature, we used the soft photoacoustic patch to measure the temperature in a phantom and checked its performance with thermocouples.
The soft photoacoustic patch can map the temperature distribution with a high spatial resolution and fast response to dynamic change. We tested ROI 2, filled with room temperature blood, under a changing thermal gradient created by all of the ROIs. We first injected blood at the room temperature into ROI 2. The blood in ROI 2 was static during the experiment. Then, we quickly injected warm and cold water into ROIs 1 and 3, respectively. The water flow in ROIs 1 and 3 stopped after the warm and cold water filling the tubes fully, which was achieved within 1 second. After the injection, fluids in ROIs 1, 2, and 3 all kept static. We used the photoacoustic patch to image the temperature gradient in ROI 2 created by all of the ROIs.
To test the feasibility of in-vivo monitoring, we used the photoacoustic patch to image veins in the forearm, monitor the venous functional response to occlusion test, and image the internal jugular vein (IJV).
Venous occlusion plethysmography is a noninvasive tool to assess the blood flow and vascular resistance of limbs. In the measurements, venous return from the forearm is briefly interrupted by inflating a cuff, wrapped around the upper arm, to above venous pressure but lower than the diastolic pressure. As a result, the venous dimension will increase as the arterial blood inflow. We attached the photoacoustic patch on the forearm, above the veins, and continuously monitored the dynamic vascular response to a venous occlusion.
We used the photoacoustic patch to 3D image the IJV (>1.1 cm in depth) in the neck (
The embodiments of the soft photoacoustic patch illustrated herein allows for continuous, noninvasive mapping of hemoglobin and core temperature with high spatial resolution in real-time. This patch can be used for 3D imaging of biomolecules in deep tissues (>2 cm in ex-vivo tests and >1.1 cm in in-vivo tests). The high-resolution imaging of hemoglobin will enable the monitoring of hemodynamics and vascular proliferation in tissues for the management of a variety of conditions and diseases. Quantifying the diameter of blood vessels can be valuable for evaluating vessel functions and diagnosing vascular diseases. For instance, measuring the dynamic change of the vein diameter during an occlusion can help examine venous compliance, which is a strong indicator of cardiac function. The photoacoustic effect-based temperature measurements, with advantages of deep penetration, high accuracy, and fast response, introduce a new strategy for monitoring the core temperature, e.g., during exercise, anesthesia, and surgical hypothermia, in fundamental biomedical research and clinical practice.
Although the photoacoustic patch discussed herein has been shown to detect hemoglobin, other embodiments can be used to monitor many other endogenous biomolecules, such as melanin, glucose, lipid, cytochrome, nucleic acid, and proteins. Furthermore, exogenous contrast agents, like single-walled carbon nanotubes, gold nanoparticles, and methylene blue, can further enhance the signal intensity, increase the detection depth, and improve the detection specificity. The laser wavelength is a key factor to selectively monitoring various biomolecules. Integrating multiple laser diodes with different wavelengths on the photoacoustic patch can expand the portfolio of detectable biomolecules, with more accurate targeting of biomolecules by detecting a set of absorption characteristics at different wavelengths. The current detection depth is still limited by the optical intensity of the VCSELs. Higher power VCSELs can be used to further increase the detection depth to the regions of visceral organs. Additionally, developing higher power VCSELs, by either fabricating larger VCSELs with more light emitting elements (see
One particular example of a fabrication process of an embodiment of the VCSEL diode chip is schematically illustrated in
In one embodiment, the fabrication process can be generalized into three steps: (1) patterning of the stretchable multilayered electrodes, (2) preparation of the VCSEL diode chips and ultrasonic transducer array, and (3) soft packaging. Cu foils with 20 μm thickness were used as the multilayered conductive interconnects. To adhere the interconnects on the soft elastomeric substrate tightly, a PI thin film [poly(pyromellitic dianhydride-co-4,40-oxydianiline) amic acid solution, PI2545 precursor, HD MicroSystems] was spin-coated on the Cu, at the speed of 4000 r.p.m. with an acceleration of 5000 r.p.m/second, for 60 seconds. The PI was cured by soft baking at 100° C. for 3 minutes and hard baking at 300° C. for 1 hour under a nitrogen atmosphere. The PI-based Cu foil was activated by ultraviolet light (PSD series Digital UV Ozone System, Novascan) for 2 minutes and then laminated on a temporary PDMS substrate (base to hardener ratio is 20:1, Sylgard 184 silicone elastomer). The ultraviolet light activation strengthens the bonding between the PI and the PDMS substrate. A nanosecond laser (Laser Mark's, central wavelength, 1059 to 1065 nm; power, 0.228 mJ; frequency, 35 kHz; speed, 300 mm/s; and pulse width, 500 ns) was used to ablate the Cu/PI into the “island-bridge” serpentine layout. The electrode patterns were designed by AutoCAD (Autodesk, USA). The patterned Cu/PI thin film was transfer-printed to an Ecoflex substrate (15 μm thick; Ecoflex-0030, Smooth-On) on a glass slide using a water-soluble tape (3M) after activation by ultraviolet light for 3 minutes. To tightly stack the second layer of the electrode on top of the first layer, a dielectric layer (15 μm) of Ecoflex was spin-coated on the first layer. Using the same method, six layers of top stimulation electrodes were built up and aligned under the microscope. The VIAs were developed by laser ablation to route all electrodes that were distributed into multiple layers to the same plane. The VCSEL array was bonded with the six-layer electrode using silver-epoxy (Esolder 3022, EIS, USA). Anisotropic conductive films (Elform) were hot pressed to the front pads of the electrodes to connect the patch to the external power supply and the data acquisition system. The bottom common ground electrode was fabricated in a similar way to the top electrodes.
The structure of the ultrasonic transducer consists of a piezoelectric material and a backing layer. 1-3 PZT-5A composites (Del Piezo, USA) were selected for some embodiments due to their excellent electromechanical coupling coefficients. The condensed backing layer was made of silver-epoxy (Esolder 3022, EIS, USA) for absorbing the extra ultrasonic wave. The silver-epoxy composite was mixed with the hardener in a 12.5:1 ratio over 10 minutes and mounted on a 0.3 mm thick mold, which was then cured at 80° ° C. for 2 hours. The same silver-epoxy was used to integrate the backing layer with the 1-3 composite material and the entire piece was diced into multiple small elements (0.8 mm length×0.6 mm width×1 mm thickness).
A scaffold with 240 holes was customized to fix the ultrasonic element arrays. Connections to the top and bottom electrodes were achieved with the conductive adhesive at 80° C. for 2 hours. The device was encapsulated by filling the device with the uncured Ecoflex precursor, followed by curing at 80° C. for 20 minutes. After that, the glass substrates of the top and bottom electrodes were peeled off. VCSEL chips and ultrasound transducers are connected to external driving and signal acquisition systems with wires. The connection of VCSEL chips can be integrated with that of the ultrasound transducers, which does not increase the complexity of the overall wearable patch compared to ultrasound sensors.
The simulation of the optical intensity distribution in a 3D space was performed by the Monte Carlo method using an open-source MATLAB toolbox—MCmatlab. A 4 cm×4 cm×4 cm homogeneous region was set as the human breast tissue, with the absorption coefficient μα, scattering coefficient μs, Henyey—Greenstein scattering anisotropy factor g, and refractive index n set as 0.1 cm−1, 85 cm−1, 0.9, and 1.3, respectively. The region above the top surface was considered as air, with μα, μs, g, and n set as 1×10−8 cm−1, 1×10−8 cm−1, 1, and 1, respectively. The laser diode array was placed at the center of the top surface. The width of each laser source was 1.5 mm. Each laser diode emitted a laser beam into the tissue perpendicular to the surface with a divergence angle of 20°. All the boundaries were set to be cuboid. The wavelength was 850 nm.
The simulation of photoacoustic detection sensitivity was performed in a 4 cm×4 cm×4 cm homogeneous region using an open-source MATLAB toolbox—k-Wave. The transducer array was placed at the center of the top surface. Assuming the background tissue as the human breast, the sound speed and tissue density were set as 1510 m/s and 1020 kg/m3, respectively. The frequency dependent acoustic absorption coefficient was considered as 0.75 dB/(MHzy·cm), where y equals to 1.5. The simulation region was divided into voxel elements with a pitch of 0.05 mm in each direction. In each voxel, one point source emitted a pulsed photoacoustic signal with the amplitude decided by the light distribution. All transducers received the pulse signal, followed by Delay-And-Sum beamforming. The amplitude of the beamformed signal was considered to be the detection sensitivity of this voxel.
The laser power of single VCSEL chip is about 40 W measured by a power meter (Newport Corporation, 835 Optical Power Meter, 818-SL detector, 883-SL attenuator), which has a sensing aperture of 11.3 mm to cover the entire light beam of one VCSEL. Considering the entire patch with a footprint of 2 cm×1.6 cm, the average power is about 1.8×103 W/m2, which is lower than the safety limit88 of 3.99×103 W/m2. Smaller pulse repetition frequency can be selected to further reduce the power if needed by specific use cases. To detect the light fields of optical beams in different cases, including a single VCSEL, and an undeformed, stretched, bent, or twisted VCSEL array, we scanned a photodetector point by point in free space to measure the optical intensity in a 2D plane. An optical attenuator (Thorlabs, NE60A-B) was fixed on the photodetector (Thorlabs, PDA10A2) to make sure the optical intensity does not exceed the measured range of the photodetector. The scanning plane was 3 cm far away from the VCSEL and VCSEL array. We measured five optical fields with a size of 2 cm×2 cm and a step size of 1 mm (
The transmitting sound field of a transducer element was measured using a hydrophone (ONDA, Model no. HNP-0400) in water tank (see
Verasonics Vantage 256 worked as the host to control the timing sequence of the whole system and signal acquisition. It has 256 individual signal acquisition channels, with built-in low-noise amplifier, programmable gain amplifier and filters. That means, each element receives the photoacoustic signal independently. All of the elements can receive the data simultaneously. Signals of four elements will be summed digitally in the MATLAB program to form one element in each virtual linear array. A program was written by MATLAB and run on the Verasonics system, controlling the laser radiation and photoacoustic signal acquisition.
To synchronize the laser emission and signal acquisition, Verasonics exported a 3.3 V LVTTL-compatible trigger signal to the signal generator (Rigol, DG822), which was a 1 μs active low output. The signal generator would be triggered to output a 5 V pulse signal with a duration of 200 ns. The laser driver (PicoLAS, LDP-V 240-100 V3.3) received the output from the signal generator, and immediately provided a 50 A current to drive the laser diodes with a pulse duration of 200 ns. The peak power of each VCSEL was 40 W driven by a 50 A pulse current. After laser illumination, the Verasonics system started the signal acquisition process. The recorded photoacoustic signal was digitized at a sampling frequency of 62.5 MHz and filtered by a bandpass filter with a center frequency of 2.2 MHz and −6 dB bandwidth of 1.2 MHz. To enhance the SNR, photoacoustic signals were averaged 3000 times to reduce the incoherent noise. Verasonics controlled the VCSELs to emit laser beams and transducers to receive signals at a pulse repetition frequency of 3 kHz, resulting in a detection frame rate of 1 Hz. A C-language program was written and called in MATLAB by the host program to reconstruct the 2D images. Reconstructing one 2D image takes about 50 ms, which means about 0.65 s is required to reconstruct all of the 13 slices of 2D images. These slices of 2D images can be shown during the measurement in real-time, which reveal information in 3D space. Converting the 2D images into 3D image is manually processed offline in a software (Amira) after saving all of the 2D images. The processing time takes less than 20 seconds. The conversion from 2D images to 3D image may be processed automatically in MATLAB in the future to save time. The time-domain signals were also saved for offline processing to reconstruct the 3D images.
The human skin and driving electrodes that connect VCSEL diodes are isolated by a 1 mm-thick Eco-flex 00-30 layer. As reported, the leakage current for such a silicon polymer layer with the same thickness is as low as 10−11 A at an applied electric field of 5 V/μm. Since the applied electric field in this study is less than 1 V/μm, the leakage current should be smaller than 10−11 A for the photoacoustic patch, which is very safe. In the ex-vivo temperature measurements (
The Coherence-Factor-weighted-Delay-And-Sum (CFDAS) algorithm was applied to reconstruct photoacoustic images. For the unmodified DAS beamforming algorithm, assuming the photoacoustic signals are measured by a transducer array with M elements, the received signal of each channel is expressed as pm(t). To reconstruct the image I(x,z) at pixel (x,z), the wave propagation time from the pixel to the m-th element is calculated as Δtm. Therefore, the image I(x,z) could be computed through the summation of Σm=1Mpm(Δtm). The CFDAS introduces an adaptive coherence factor as an additional weight to Σm=1Mpm(Δtm), which is
CFDAS has been demonstrated to improve the image quality91 (
The NIR-UV-Vis measurements were carried out through a PerkinElmer lambda 1050 UV/Vis/NIR Spectrometer. Water absorbance spectrum was measured under 150 mm InGaAs Int. Sphere Absorbance module and the rest were carried out through 3D WB Det. Absorbance Module. Before each measurement, a 100% transmittance (0 absorbance) baseline was autozeroed. The water spectrum was denoised through white certified reflectance standard from Labsphere Company while the rest background was calibrated with pure water. The detection cuvette had a transmittance length of 5 mm. The injected beam (Slit width of 2.00 nm) was sourced from the combination of D2 Lamp and Tungsten Lamp with a lamp change at 860.8 nm. The spectra were collected in the wavelength range from 1000 nm to 700 nm with a data interval of 1 nm.
The ultrasound B-mode images were acquired by the Verasonics Vantage 256 with an L11-5v linear array. The center frequency of the probe was 7.8 MHz. The compounding imaging strategy was applied to reconstruct the images, which transmitted plane waves in 21 directions, received the echoes, and combined them all to form a single image.
For the venous occlusion demonstration, the volunteer sat on a chair with a pressure cuff worn on the upper arm. The vertical distance between the neck and the forearm was about 30 cm. Then we attached the photoacoustic patch on the forearm above the veins using a medical tape. After that, a venous occlusion test was performed: (1) inflate the cuff to 70 mmHg immediately and maintain for 60 seconds; (2) deflate the cuff to zero to let the veins recover to the normal status. All of the photoacoustic signals were saved during the experiment. In the detection of the internal jugular vein, the volunteer sat on a chair with the photoacoustic patch attached to the neck with a medical tape. For the imaging of veins in the forearm and venous occlusion test, a 1 cm-thick gelatin phantom was placed between the patch and forearm to compensate non-uniform light distribution (see
For a photoacoustic imaging system, important sensing components are (1) laser sources for exciting the target molecules to generate photoacoustic waves and (2) piezoelectric transducers for detecting acoustic waves. Conventionally, the optical sources used in the photoacoustic system can be divided into three categories. The first type is the conventional high-power laser system, whose peak pulse power is usually on the order of millijoule with a penetration depth spanning from 3 mm to 4 cm. These high-power lasers are mostly used to provide strong light intensity to excite the target molecules to generate photoacoustic waves. Operating these lasers needs strict trainings and to be in laboratories that meet high safety standards. Additionally, these laser systems are costly and bulky, which are not suitable for wearable applications.
The second type of optical source is the hand-held compact laser with a relatively lower energy than the first type. A typical laser of this kind has a size as small as 160 mm×64 mm×40 mm37. Still, they are too large to be suitable for continuous wearing. The third type is light-emitting diodes or laser diodes. Although some photoacoustic systems employ light-emitting diodes and laser diodes as the optical source, they still rely on bulky rigid ultrasound probes to receive the acoustic waves. Those ultrasound probes require manual holding and the subject to be static during testing. Additionally, they use edge-emitting semiconductor laser diodes, which are not suitable to be integrated into a conformal patch because the edge-emitting semiconductor laser diodes usually have a large size (more than several millimeters) in the emission direction.
The photoacoustic patch in this work integrates both the laser source and the piezoelectric transducer into a low form factor conformal patch (e.g., 20 mm×16 mm×1.2 mm), by encapsulating an array of laser diode chips (e.g., 1.7 mm×2.4 mm×0.4 mm) and transducer elements (e.g., 0.6 mm×0.8 mm×1.0 mm) into a flexible and stretchable silicone polymer matrix. In terms of the complexity of system, we have significantly simplified a conventional photoacoustic imaging system by replacing the bulky laser source with surface-mounted laser diode dies. Although the VCSEL chips (e.g., <$10 each) may increase the cost compared to an ultrasound patch, it greatly reduces the cost of conventionally used laser sources. In addition, the cost of each VCSEL die chip can further be reduced if the quantity of chips is increased. The stretchability of the overall patch is enabled by the serpentine shaped metal electrodes that interconnect the laser diode chips and the transducer elements. The device is rigid locally at the laser diode chips and the transducer elements but is soft globally on the system level. The penetration depth of this soft photoacoustic patch in tissues can reach >2 cm. The technology is exceptionally suitable for wearable health monitoring without immobilizing the test subjects.
To develop a fully integrated wearable system to meet future needs, handling the quantity of data needs to be addressed. Different clinical cases require different quantities of continuous imaging for clinical application. The monitoring period extends from several minutes to several days. Assuming each 2D image has a size of 2 cm×2 cm, composed of 200×200 pixels, one 2D image would occupy ˜39 KB for 1-byte unsigned integer data type. Thus, 13 slices will be ˜507 KB. To be specific, continuous monitoring for 5 minutes, 5 hours, or 5 days will create datasets with the size of about 149 MB, 8.7 GB, and 209 GB, respectively. Such file sizes are easy to be accommodated since common commercial hard disks have space larger than several Terabytes. To handle these data for a completely portable system, one solution is to transfer the image data from the portable system to an external data storage equipment, which can be easily achieved by USB 2.0 cables (data transfer speed >60 MB/s) or WiFi (data transfer speed >2.5 MB/s).
It is worth mentioning that the big difference of optical intensity between high power lasers and laser diode chips may have influence on the detection of non-static tissues. Because the high-power laser has very strong light intensity, it can generate strong photoacoustic signals with only one pulse. Pulsation of the tissues (e.g., major arteries) will not affect the imaging result. However, for laser diode chip based photoacoustic systems, the light intensity and therefore photoacoustic signals are relatively weak. Averaging several thousands of signals are required to increase the signal-to-noise ratio. Acquiring several thousands of signals may take one second or even a longer time, during which the photoacoustic signal will move forward and back due to movements of the tissue, resulting in unstable phases of the photoacoustic signals, and thus destroying the coherent averaging (
Near-infrared light has high penetration depth in human tissues compared to the visible light because of its weak scattering and absorption. For probing human tissues, three commonly used optical windows are in the range of 650˜950 nm, 1000˜1350 nm, and 1600˜1870 nm. In the first window, hemoglobin still has a higher optical absorption than water and lipid. Therefore, photoacoustic signals of hemoglobin can be generated with low background noise. No extra contrast agent is needed to highlight the hemoglobin. In the second window, the penetration depth increases. But additional contrast agents are needed to label the hemoglobin molecules because of their low absorption coefficients. The third window has even deeper penetration because of reduced scattering, but is rarely used due to the dominant water absorption, suppressing the detection of other molecules.
The gold standard for measuring the core temperature is to use a catheter to measure the temperature in the pulmonary artery, which is too invasive for routine measurements. Implantable devices with biocompatibility can be directly fixed in the human body, thus providing accurate and continuous temperature measurements in deep tissues. However, in a lot of cases, the infection risks, application complexity, data communication, and power supplies of the implantable devices introduce more challenges than benefits.
There are various strategies for noninvasive temperature measurements of the human body. Wearable skin-like soft sensors usually integrate temperature sensitive electronic components, such as the thermistor, the ion conductor, and the thermocouple. But they can only measure the temperature on the skin surface. Magnetic resonance imaging can quantify the internal temperature variance at a depth >10 cm and spatial resolution of 2 mm. However, owing to the bulky and expensive system, it is not realistic to use MRI in daily activities.
Wearable sensors that can measure core temperatures are developed mostly based on the zero-heat-flux model and the dual-heat-flux model. In the zero-heat-flux model, when the skin and deep tissue temperatures are considered identical, there will be no heat flow between them. As a result, the core temperature is the same as the skin surface temperature. Nevertheless, these sensors require external heaters to achieve a thermal equilibrium between the skin surface and the core body and thus have a relatively long response time (>180 s), especially at a considerable depth underneath the skin. To eliminate the use of the heater, sensors based on the dual heat flux model are developed. But this method requires an even longer response time (˜447 s) and it is imprecise since it is only a predicted value.
Compared to the existing methods, the photoacoustic patch described herein has multiple advantages, including high penetration depth (>2 cm on tissues), short response time (˜1 s), and soft mechanical design for continuous wearing. Furthermore, this technology can provide 3D temperature mapping with a lateral resolution of 0.59 mm and an axial resolution of 0.86 mm at a depth of 2 cm.
Generating the photoacoustic waves is a process of converting optical energy to mechanical vibration energy. After the laser illumination, biomolecules (e.g., hemoglobin in this work) will absorb the optical energy, undergo thermoelastic expansion, and radiate acoustic waves into the surrounding media. For a nanosecond laser source, the generation of photoacoustic waves satisfies the stress and thermal confinements. The photoacoustic signal amplitude can be express as:
where I′ is the Grüneisen parameter, μa is the absorption coefficient, and F is the laser fluence. During the test, the light fluence F is a constant for the same laser source. μa also keeps unchanged for the same type of biomolecule. The Grüneisen parameter is what changes the signal amplitude, and linear to the temperature in the range of 10˜ 55° C. Therefore, the photoacoustic signal and the temperature show a linear relationship in the vicinity of human core temperature (˜37° C.). The Grüneisen parameter Γ can be expressed as:
where Γ0 is the value at temperature T0, a is a constant decided by the tissue type. The photoacoustic signal amplitude can be rewritten as:
The photoacoustic signal can quantify the temperature after calibrating αμaF and Γ0μaF, which can be considered as the slope and intercept of a linear function, respectively.
Pure ultrasound techniques can also noninvasively measure the temperature in deep tissue because the tissue temperature will change the sound speed. However, there are some limitations for temperature measurements with ultrasound. First, the biggest problem is that ultrasonography can only detect the contrast of acoustic impedance, which means ultrasound collects anatomical information. As ultrasonography cannot distinguish different biomolecules, it cannot recognize the inclusion components inside cysts, which is critical for determining if the cyst is benign or malignant. Second, ultrasonography may suffer from low contrast to recognize small blood vessels. Photoacoustic imaging, as a new and promising biomedical imaging technique, has made a lot of advances in the last two decades. Since the photoacoustic signal originates from the light absorption, photoacoustic imaging holds optical contrast, rather than the acoustic impedance contrast. In addition, photoacoustic imaging combines the best of two worlds: generating signal optically and sensing signal acoustically, which makes photoacoustic imaging best for high-resolution high-contrast imaging of biomolecules in deep tissues. Third, for temperature sensing, ultrasound has a much lower sensitivity than photoacoustics. A quantitative comparison between these two methods has been described. For instance, assuming the temperature of water increases from 20 to 30° C., the sound speed will increase from ˜1481 to ˜1507 m/s, with a relative change of sound speed only ˜0.176% per degree centigrade. On the other side, the photoacoustic signal amplitude will be enhanced by 51% for such a 10° C. increase, resulting in a relatively large amplitude change of ˜5.1% per degree centigrade.
Bland-Altman plot analyzes the agreement between two pair of datasets. This plot is widely used in statistics in analytical chemistry as well as biomedicine to compare a new measurement method with the gold standard. Assuming the datasets measured by the two methods are X and Y, the y-coordinate of the Bland-Altman plot are the differences in each paired X and Y values, while the x-coordinate represents the average value of X and Y. In Bland-Altman plot, there are three horizontal lines, representing the mean bias
E
upper
=
E
lower
=
where sd is the standard deviation. 1.96 is the boundary of the 95-confidence interval in standard normal distribution. It means that the probability of the population mean value is between −1.96 and 1.96 standard deviations.
To examine the influence of irregular human neck curvature on the imaging performance of the soft photoacoustic patch, the skin curvature distribution was characterized. We used a 3D scanner (HDI Advances, LMI Technologies, Vancouver, Canada) to scan the area above the internal jugular vein (see
To quantify the influence of the skin curvature on the imaging performance, the generation process of the photoacoustic signals was then simulated in a MATLAB toolbox—k-Wave. Seven equally distributed point sources were set at the depth of 5, 7.5, 10, 12.5, 15, 17.5, and 20 mm in human tissues. The ultrasound array of a 2 MHz center frequency was placed at the depth of 0 mm. The spatial mesh in each direction was set to be 0.05 mm, much smaller than the ultrasound wavelength of 0.77 mm to ensure high accuracy. The sampling frequency was 62.5 MHz, the same as the experimental setup. The background media was considered as breast tissues. The sound speed and tissue density were set as 1510 m/s and 1020 kg/m3, respectively. The frequency dependent acoustic absorption coefficient was considered as 0.75 dB/(MHzy·cm), where y equals to 1.5. The Coherence Factor weighted Delay And Sum algorithm was applied to reconstruct the photoacoustic images, with the ultrasound array set as a planar and a curvilinear array.
The continuous detection of melanin could have potential applications in close monitoring metastasis of melanoma tumor cells. In addition, melanoma has a very high possibility of metastasis, which causes more than 90% cancer related mortality. Detection and monitoring of metastasis of melanoma tumor cells can help staging the cancer and take effective means of medical intervention at the early stage. Continuous monitoring of circulating melanoma tumor cells has been well studied. Photothermal therapy has also been used to kill circulating tumors with the assistance of continuous photoacoustic imaging.
For the detection of glucose, cytochormes and nucleic acid, many studies have actually demonstrated both in-vitro and in-vivo label-free imaging using photoacoustic techniques. But for now, photoacoustic imaging is not mature as a reliable technique to continuously monitor humans due to technical and regulatory challenges.
As for exogenous contrast agents, one typical example is indocyanine green (ICG), which has been approved by Food and Drug Administration due to its high biosafety. ICG was not only widely used in photoacoustic imaging studies, but also well established in clinical applications in the field of other optical imaging technique. Specifically for photoacoustic imaging, ICG has been used in the vena mediana cubiti of the right arm of a human volunteer to enhance the monitoring of blood haemodynamics in the finger. In a much more comprehensive study, metastatic status of sentinel lymph nodes in melanoma has been detected with the administration of ICG in 20 patients. The latter study demonstrates that patients can benefit from ICG-assisted photoacoustic imaging for clinical management of melanoma.
Both in ultrasound B-mode imaging and photoacoustic imaging, the coherence factor weighted DAS beamforming has been demonstrated to suppress the grating lobes. The second row of images show the CFDAS algorithm decreases the impact of grating lobes.
1
3
5
7
9, 10
11
12
53
50-52
58
27
Certain aspects of the wearable stretchable and/or flexible imaging device described herein are presented in the foregoing description and illustrated in the accompanying drawing using electronic hardware, computer software, or any combination thereof. Whether such elements are implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. By way of example, such elements, or any portion of such elements, or any combination of such elements may be implemented with one or more processors or controllers. Examples of processors or controllers include microprocessors, microcontrollers, digital signal processors (DSPs), field programmable gate arrays (FPGAs), programmable logic devices (PLDs), state machines, gated logic, discrete hardware circuits, and any other suitable hardware configured to perform the various functionalities described throughout this disclosure. Examples of processors or controllers may also include general-purpose computers or computing platforms selectively activated or reconfigured by code to provide the necessary functionality.
The foregoing description, for the purpose of explanation, has been described with reference to specific embodiments. However, the illustrative discussions above are not intended to be exhaustive or to limit the invention to the precise forms disclosed. Many modifications and variations are possible in view of the above teachings. The embodiments were chosen and described in order to best explain the principles of the embodiments and its practical applications, to thereby enable others skilled in the art to best utilize the embodiments and various modifications as may be suited to the particular use contemplated. Accordingly, the present embodiments are to be considered as illustrative and not restrictive, and the invention is not to be limited to the details given herein, but may be modified within the scope and equivalent of the appended claims.
This application is a National Phase in the United States of Application No. PCT/US2022/030516, filed May 22, 2022, which claims the benefit of U.S. Provisional Application No. 63/191,374, filed May 21, 2021, the contents of which are incorporated herein by reference.
This invention was made with government support under EB027303 awarded by the National Institutes of Health. The government has certain rights in the invention.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US22/30516 | 5/23/2022 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 63191374 | May 2021 | US |